Ictal and interictal brain SPECT imaging in epilepsy using technetium- 99m-ECD

F. Grunwald, C. Menzel, L. Pávics, J. Bauer, A. Hufnagel, K. Reichmann, R. Sakowski, C. E. Elger, H. J. Biersack

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

The aim of this study was to evaluate the use of 99mTc-ethyl cysteinate dimer (ECD), also known as 99mTc-bicisate, in the presurgical evaluation of patients suffering from medically intractable epilepsy. Methods: Twenty- three brain SPECT studies (8 ictally and 15 interictally) were performed on 16 patients with a high-resolution annular SPECT system (CERASPECT). For the ictal studies, the tracer was injected in the very early phase of the seizure. The delay between seizure onset and 99mTc-ECD injection was 2-20 sec. Results: Interictally, all patients showed circumscribed hypoperfusions. In four patients, the SPECT lesion represented only structural defects. Circumscribed increased tracer uptake was observed in all ictal studies. For all patients with temporal lobe epilepsy without significant mass lesion, in whom an interictal and ictal 99mTc-ECD-SPECT study could be obtained, the asymmetry index was 0.88 ± 0.03 for the interictal and 1.23 ± 0.08 for the ictal studies. Conclusion: The data suggest that 99mTc-ECD is an effective marker of cerebral perfusion imaging in epilepsy. In comparison to other tracers, it has a high in vitro stability and is therefore particularly useful for ictal studies in the very early phase after seizure onset.

Original languageEnglish
Pages (from-to)1896-1901
Number of pages6
JournalJournal of Nuclear Medicine
Volume35
Issue number12
Publication statusPublished - 1994

Fingerprint

Technetium
Single-Photon Emission-Computed Tomography
Neuroimaging
Epilepsy
Stroke
Seizures
Perfusion Imaging
Temporal Lobe Epilepsy
ethyl cysteinate dimer
Injections
technetium Tc 99m bicisate
Brain

Keywords

  • brain SPECT
  • epilepsy
  • technetium-99m-ECD

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Grunwald, F., Menzel, C., Pávics, L., Bauer, J., Hufnagel, A., Reichmann, K., ... Biersack, H. J. (1994). Ictal and interictal brain SPECT imaging in epilepsy using technetium- 99m-ECD. Journal of Nuclear Medicine, 35(12), 1896-1901.

Ictal and interictal brain SPECT imaging in epilepsy using technetium- 99m-ECD. / Grunwald, F.; Menzel, C.; Pávics, L.; Bauer, J.; Hufnagel, A.; Reichmann, K.; Sakowski, R.; Elger, C. E.; Biersack, H. J.

In: Journal of Nuclear Medicine, Vol. 35, No. 12, 1994, p. 1896-1901.

Research output: Contribution to journalArticle

Grunwald, F, Menzel, C, Pávics, L, Bauer, J, Hufnagel, A, Reichmann, K, Sakowski, R, Elger, CE & Biersack, HJ 1994, 'Ictal and interictal brain SPECT imaging in epilepsy using technetium- 99m-ECD', Journal of Nuclear Medicine, vol. 35, no. 12, pp. 1896-1901.
Grunwald F, Menzel C, Pávics L, Bauer J, Hufnagel A, Reichmann K et al. Ictal and interictal brain SPECT imaging in epilepsy using technetium- 99m-ECD. Journal of Nuclear Medicine. 1994;35(12):1896-1901.
Grunwald, F. ; Menzel, C. ; Pávics, L. ; Bauer, J. ; Hufnagel, A. ; Reichmann, K. ; Sakowski, R. ; Elger, C. E. ; Biersack, H. J. / Ictal and interictal brain SPECT imaging in epilepsy using technetium- 99m-ECD. In: Journal of Nuclear Medicine. 1994 ; Vol. 35, No. 12. pp. 1896-1901.
@article{b9fb7cfca9744633b7bb4790773c1df2,
title = "Ictal and interictal brain SPECT imaging in epilepsy using technetium- 99m-ECD",
abstract = "The aim of this study was to evaluate the use of 99mTc-ethyl cysteinate dimer (ECD), also known as 99mTc-bicisate, in the presurgical evaluation of patients suffering from medically intractable epilepsy. Methods: Twenty- three brain SPECT studies (8 ictally and 15 interictally) were performed on 16 patients with a high-resolution annular SPECT system (CERASPECT). For the ictal studies, the tracer was injected in the very early phase of the seizure. The delay between seizure onset and 99mTc-ECD injection was 2-20 sec. Results: Interictally, all patients showed circumscribed hypoperfusions. In four patients, the SPECT lesion represented only structural defects. Circumscribed increased tracer uptake was observed in all ictal studies. For all patients with temporal lobe epilepsy without significant mass lesion, in whom an interictal and ictal 99mTc-ECD-SPECT study could be obtained, the asymmetry index was 0.88 ± 0.03 for the interictal and 1.23 ± 0.08 for the ictal studies. Conclusion: The data suggest that 99mTc-ECD is an effective marker of cerebral perfusion imaging in epilepsy. In comparison to other tracers, it has a high in vitro stability and is therefore particularly useful for ictal studies in the very early phase after seizure onset.",
keywords = "brain SPECT, epilepsy, technetium-99m-ECD",
author = "F. Grunwald and C. Menzel and L. P{\'a}vics and J. Bauer and A. Hufnagel and K. Reichmann and R. Sakowski and Elger, {C. E.} and Biersack, {H. J.}",
year = "1994",
language = "English",
volume = "35",
pages = "1896--1901",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "12",

}

TY - JOUR

T1 - Ictal and interictal brain SPECT imaging in epilepsy using technetium- 99m-ECD

AU - Grunwald, F.

AU - Menzel, C.

AU - Pávics, L.

AU - Bauer, J.

AU - Hufnagel, A.

AU - Reichmann, K.

AU - Sakowski, R.

AU - Elger, C. E.

AU - Biersack, H. J.

PY - 1994

Y1 - 1994

N2 - The aim of this study was to evaluate the use of 99mTc-ethyl cysteinate dimer (ECD), also known as 99mTc-bicisate, in the presurgical evaluation of patients suffering from medically intractable epilepsy. Methods: Twenty- three brain SPECT studies (8 ictally and 15 interictally) were performed on 16 patients with a high-resolution annular SPECT system (CERASPECT). For the ictal studies, the tracer was injected in the very early phase of the seizure. The delay between seizure onset and 99mTc-ECD injection was 2-20 sec. Results: Interictally, all patients showed circumscribed hypoperfusions. In four patients, the SPECT lesion represented only structural defects. Circumscribed increased tracer uptake was observed in all ictal studies. For all patients with temporal lobe epilepsy without significant mass lesion, in whom an interictal and ictal 99mTc-ECD-SPECT study could be obtained, the asymmetry index was 0.88 ± 0.03 for the interictal and 1.23 ± 0.08 for the ictal studies. Conclusion: The data suggest that 99mTc-ECD is an effective marker of cerebral perfusion imaging in epilepsy. In comparison to other tracers, it has a high in vitro stability and is therefore particularly useful for ictal studies in the very early phase after seizure onset.

AB - The aim of this study was to evaluate the use of 99mTc-ethyl cysteinate dimer (ECD), also known as 99mTc-bicisate, in the presurgical evaluation of patients suffering from medically intractable epilepsy. Methods: Twenty- three brain SPECT studies (8 ictally and 15 interictally) were performed on 16 patients with a high-resolution annular SPECT system (CERASPECT). For the ictal studies, the tracer was injected in the very early phase of the seizure. The delay between seizure onset and 99mTc-ECD injection was 2-20 sec. Results: Interictally, all patients showed circumscribed hypoperfusions. In four patients, the SPECT lesion represented only structural defects. Circumscribed increased tracer uptake was observed in all ictal studies. For all patients with temporal lobe epilepsy without significant mass lesion, in whom an interictal and ictal 99mTc-ECD-SPECT study could be obtained, the asymmetry index was 0.88 ± 0.03 for the interictal and 1.23 ± 0.08 for the ictal studies. Conclusion: The data suggest that 99mTc-ECD is an effective marker of cerebral perfusion imaging in epilepsy. In comparison to other tracers, it has a high in vitro stability and is therefore particularly useful for ictal studies in the very early phase after seizure onset.

KW - brain SPECT

KW - epilepsy

KW - technetium-99m-ECD

UR - http://www.scopus.com/inward/record.url?scp=0028104712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028104712&partnerID=8YFLogxK

M3 - Article

VL - 35

SP - 1896

EP - 1901

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 12

ER -